Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $804000.0.

  • Rapid Micro Biosystems' Depreciation & Amortization (CF) fell 640.28% to $804000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 133.86%. This contributed to the annual value of $3.4 million for FY2024, which is 827.7% up from last year.
  • Latest data reveals that Rapid Micro Biosystems reported Depreciation & Amortization (CF) of $804000.0 as of Q3 2025, which was down 640.28% from $811000.0 recorded in Q2 2025.
  • Over the past 5 years, Rapid Micro Biosystems' Depreciation & Amortization (CF) peaked at $869000.0 during Q4 2024, and registered a low of $300000.0 during Q2 2021.
  • Over the past 5 years, Rapid Micro Biosystems' median Depreciation & Amortization (CF) value was $781000.0 (recorded in 2023), while the average stood at $697894.7.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first tumbled by 2500.0% in 2021, then skyrocketed by 12766.67% in 2022.
  • Rapid Micro Biosystems' Depreciation & Amortization (CF) (Quarter) stood at $450000.0 in 2021, then surged by 91.11% to $860000.0 in 2022, then fell by 7.67% to $794000.0 in 2023, then grew by 9.45% to $869000.0 in 2024, then decreased by 7.48% to $804000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $804000.0 in Q3 2025, compared to $811000.0 in Q2 2025 and $847000.0 in Q1 2025.